KR950007808A - 약물투여용 의료용구 - Google Patents

약물투여용 의료용구 Download PDF

Info

Publication number
KR950007808A
KR950007808A KR1019940020906A KR19940020906A KR950007808A KR 950007808 A KR950007808 A KR 950007808A KR 1019940020906 A KR1019940020906 A KR 1019940020906A KR 19940020906 A KR19940020906 A KR 19940020906A KR 950007808 A KR950007808 A KR 950007808A
Authority
KR
South Korea
Prior art keywords
drug
gel
medical device
drug administration
patch
Prior art date
Application number
KR1019940020906A
Other languages
English (en)
Inventor
파올로 카바자
Original Assignee
알도 파시
아방가르드 에스. 피. 에이.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 알도 파시, 아방가르드 에스. 피. 에이. filed Critical 알도 파시
Publication of KR950007808A publication Critical patent/KR950007808A/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7092—Transdermal patches having multiple drug layers or reservoirs, e.g. for obtaining a specific release pattern, or for combining different drugs

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

본 발명은 극소량의 약물 또는 극소량의 유효성분, 특히 동종요법 약물(Homeopathic drugs)의 투여용 의료용구에 관한 것이다.

Description

약물투여용 의료용구
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음
제1도는 경피투여 패치의 단면도이다.

Claims (2)

  1. 극소량의 약물 또는 유효성분을 투여하기 위한 약물투여용 의료용구에 있어서, (가) 피부에 도포시키는 패치의 외피에 해당하는 지지막(1)과; (나)패치의 부착을 위한 접촉면으로서 패치 외피의 반대편에 위치하는 다공성 접작층(3)과; (다)지지막(1)과 다공성 접착층(3) 사이에 있으면서 약물의 방출을 조절하는 미세기공막(2)및; (라)투여하고자 하는 동중요법 약물(5)이 분산되어 있는 겔(6)로 이루어져 있되; 상기 미세기공막(2)의 상부에는 약물 저장고 역할을 겔영역(6a)이 있고, 그 하부는 상부 겔영역(6a)보다 약물 농도가 낮은 겔영역(6b)으로 이루어져 있는 것을 특징으로 하는 약물투여용 의료용구.
  2. 제1항에 있어서, 상기 겔(6)은 글리세린, 증류수, 락토스, 폴리(비닐알콜), 폴리(비닐-2-피롤리돈) 및 시트르산 나트륨으로 이루어져 있는 것을 특징으로 하는 약물투여용 의료용구.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019940020906A 1993-09-02 1994-08-24 약물투여용 의료용구 KR950007808A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ITRM93A000591 1993-09-02
ITRM930591A IT1261849B (it) 1993-09-02 1993-09-02 Dispositivo medico per la somministrazione di principi attivi o farmaci a bassissimo dosaggio, in particolare di farmaci omeopatici.

Publications (1)

Publication Number Publication Date
KR950007808A true KR950007808A (ko) 1995-04-15

Family

ID=11401933

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019940020906A KR950007808A (ko) 1993-09-02 1994-08-24 약물투여용 의료용구

Country Status (12)

Country Link
US (1) US5683712A (ko)
EP (1) EP0641561B1 (ko)
JP (1) JPH07165566A (ko)
KR (1) KR950007808A (ko)
AT (1) ATE173162T1 (ko)
CA (1) CA2129760A1 (ko)
DE (1) DE69414502T2 (ko)
DK (1) DK0641561T3 (ko)
ES (1) ES2125380T3 (ko)
GR (1) GR3029308T3 (ko)
IT (1) IT1261849B (ko)
ZA (1) ZA946698B (ko)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6475514B1 (en) 1998-12-03 2002-11-05 Andrew Blitzer Athletic patch
GB2354636A (en) * 1999-09-25 2001-03-28 Ibm Mounting chips on substrates
FR2806910B1 (fr) * 2000-04-03 2003-01-24 Dolisos Lab Procede d'inactivation virale de solutions hydro-alcooliques
RU2181297C2 (ru) 2000-06-20 2002-04-20 Эпштейн Олег Ильич Способ лечения патологического синдрома и лекарственное средство
US20030022206A1 (en) * 2001-05-16 2003-01-30 Kay Robert A. Method of characterizing a homeopathic preparation
US20040009180A1 (en) * 2002-07-11 2004-01-15 Allergan, Inc. Transdermal botulinum toxin compositions
UA76641C2 (uk) * 2002-08-02 2006-08-15 Олєг Ільіч Епштєйн Гомеопатичний лікарський засіб та спосіб лікування захворювань передміхурової залози
UA76639C2 (uk) * 2002-08-02 2006-08-15 Олєг Ільіч Епштєйн Гомеопатичний лікарський засіб та спосіб лікування еректильних дисфункцій
UA76638C2 (en) * 2002-08-02 2006-08-15 Oleh Illich Epshtein Homeopathic medication based on anti-interferon antibodies and method for treating a pathological syndrome associated with interferon
UA76640C2 (uk) * 2002-08-02 2006-08-15 Олєг Ільіч Епштєйн Спосіб корекції патологічних імунних реакцій та гомеопатичний лікарський засіб
US20050255139A1 (en) * 2004-05-14 2005-11-17 Hurd Jonathan L Polymeric compositions with embedded pesticidal desiccants
US20060188558A1 (en) * 2005-02-18 2006-08-24 Mylan Technologies, Inc. Transdermal systems having control delivery system
US9486408B2 (en) 2005-12-01 2016-11-08 University Of Massachusetts Lowell Botulinum nanoemulsions
TR201901443T4 (tr) 2005-12-01 2019-02-21 Univ Massachusetts Lowell Botulinum nanoemülsiyonları.
RU2309732C1 (ru) * 2006-03-13 2007-11-10 Олег Ильич Эпштейн Спрессованная твердая оральная форма лекарственного препарата и способ получения твердой оральной формы лекарственного препарата
WO2008039245A2 (en) 2006-04-27 2008-04-03 Anterios, Inc. Assessment of the effects of topical administration of chemodenervating pharmaceuticals
JP5687425B2 (ja) * 2006-06-06 2015-03-18 オレグ イリッチ エプシュテイン 肥満、真性糖尿病及び耐糖能異常を伴う疾患の治療用薬剤
BRPI0719732A2 (pt) 2006-12-01 2017-05-16 Anterios Inc nanopartículas de peptídeo e usos para as mesmas
EP2494958A1 (en) 2006-12-01 2012-09-05 Anterios, Inc. Amphiphilic Entity Nanoparticles
US8940326B2 (en) 2007-03-19 2015-01-27 Vita Sciences Llc Transdermal patch and method for delivery of vitamin B12
ES2660906T3 (es) 2007-05-31 2018-03-26 Anterios, Inc. Nanopartículas de ácido nucleico y usos de las mismas
US20090047334A1 (en) * 2007-08-13 2009-02-19 Patricia Williams Transdermal patch for extended delivery of calcium
WO2009158687A1 (en) 2008-06-26 2009-12-30 Anterios, Inc. Dermal delivery
KR101901465B1 (ko) 2010-07-15 2018-09-21 올레그 일리치 엡쉬테인 위장관의 기능적 질환 또는 상태를 치료하는 제약학적 복합 조성물 및 방법들
CN103154028A (zh) 2010-07-15 2013-06-12 奥列格·伊里奇·爱泼斯坦 复合药物组合物以及对神经退行性疾病相关的疾病或病症进行治疗的方法
SG187038A1 (en) 2010-07-15 2013-02-28 Oleg Iliich Epshtein A method of increasing the effect of an activated-potentiated form of an antibody
JP6158082B2 (ja) 2010-07-17 2017-07-05 メルク パテント ゲーエムベーハー 浸透と作用の増強
UA112755C2 (uk) 2010-07-21 2016-10-25 Олєг Ільіч Епштейн Метод лікування синдрому дефіциту уваги і гіперактивності
CA2805978C (en) 2010-07-21 2016-06-28 Oleg Iliich Epshtein Combination pharmaceutical composition and methods of treating diseases or conditions associated with respiratory disease or condition
AU2012209274A1 (en) 2011-01-24 2013-09-12 Anterios, Inc. Nanoparticle compositions, formulations thereof, and uses therefor
US20120328549A1 (en) 2011-01-24 2012-12-27 Anterios, Inc. Oil compositions
KR20140003572A (ko) 2011-01-24 2014-01-09 안테리오스, 인코퍼레이티드 나노입자 조성물
US20120225018A1 (en) * 2011-03-03 2012-09-06 Nancy Josephine Polich Homeopathic therapeutic method and compositions
US10022335B2 (en) 2011-03-03 2018-07-17 Nancy Josephine Polich Homeopathic therapeutic method and compositions
PT2683385T (pt) 2011-03-10 2018-10-19 Rigel Pharmaceuticals Inc Pirimidinadiaminas 2,4-substituídas para utilização no lúpus discoide
WO2012129519A1 (en) 2011-03-23 2012-09-27 Deseret Biologicals, Inc. Formulations of diluted amino acid segments and methods for making same
BE1020027A3 (fr) 2011-06-23 2013-04-02 Jean Pierre Mageren Compositions homeopathiques pour le traitement des douleurs du dos et des sciatiques.
WO2013163176A1 (en) 2012-04-23 2013-10-31 Allertein Therapeutics, Llc Nanoparticles for treatment of allergy
KR101365321B1 (ko) * 2012-05-22 2014-02-20 제일약품주식회사 매트릭스내 비스테로이드성 소염진통제의 농도구배를 이용하여 경피투과도를 향상시킨 패취제
WO2014043257A1 (en) 2012-09-12 2014-03-20 Rigel Pharmaceuticals, Inc. Treatment for vitiligo
JP2016516754A (ja) 2013-04-03 2016-06-09 アラーテイン・セラピューティクス・リミテッド・ライアビリティ・カンパニーＡｌｌｅｒｔｅｉｎ Ｔｈｅｒａｐｅｕｔｉｃｓ， ＬＬＣ 新規のナノ粒子組成物
WO2015168564A1 (en) 2014-05-01 2015-11-05 Anterios, Inc. Methods to treat, prevent, and improve skin conditions
CA2993288A1 (en) 2015-07-24 2017-02-02 Glaxo Group Limited Treatment for vitiligo
KR102487144B1 (ko) 2016-11-21 2023-01-12 에이리온 테라퓨틱스, 인코포레이티드 큰 물질의 경피 전달
CN112351992A (zh) 2017-12-20 2021-02-09 阿勒根公司 肉毒杆菌毒素细胞结合结构域多肽及其用于皮肤再生的方法
WO2020056191A1 (en) 2018-09-13 2020-03-19 Eirion Therapeutics, Inc. Uses of plasminogen activator inhibitor 1 (pai-1) inhibitors
WO2020056160A1 (en) 2018-09-13 2020-03-19 Eirion Therapeutics, Inc. Plasminogen activator inhibitor 1 (pai-1) inhibitors and uses therefor
AU2019391791A1 (en) 2018-12-03 2021-06-03 Eirion Therapeutics, Inc. Improved delivery of large agents
BR112021022619A2 (pt) 2019-05-14 2022-01-04 Eirion Therapeutics Inc Retardo de efeito de pico e/ou prolongamento de duração de resposta

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4060084A (en) * 1976-09-07 1977-11-29 Alza Corporation Method and therapeutic system for providing chemotherapy transdermally
US4605548A (en) * 1983-05-31 1986-08-12 Nitto Electric Industrial Co., Ltd. Drug administration material
US4788064A (en) * 1987-07-31 1988-11-29 Warner-Lambert Company Transdermal delivery system
WO1992006701A1 (en) * 1990-10-18 1992-04-30 Huffstutler, M., Conrad, Jr. Preparation of concentrated fluid symphytum extracts, therapeutic forms and methods of use

Also Published As

Publication number Publication date
ZA946698B (en) 1995-05-02
JPH07165566A (ja) 1995-06-27
CA2129760A1 (en) 1995-03-03
US5683712A (en) 1997-11-04
DE69414502D1 (de) 1998-12-17
IT1261849B (it) 1996-06-03
EP0641561B1 (en) 1998-11-11
ITRM930591A1 (it) 1995-03-02
GR3029308T3 (en) 1999-05-28
DK0641561T3 (da) 1999-07-26
ITRM930591A0 (it) 1993-09-02
EP0641561A3 (en) 1995-09-27
EP0641561A2 (en) 1995-03-08
ATE173162T1 (de) 1998-11-15
DE69414502T2 (de) 1999-04-08
ES2125380T3 (es) 1999-03-01

Similar Documents

Publication Publication Date Title
KR950007808A (ko) 약물투여용 의료용구
US4230105A (en) Transdermal delivery of drugs
US5415866A (en) Topical drug delivery system
US6120792A (en) Medicated skin patch and method for its use
KR900700153A (ko) 생리학적 활성물질 투여를 위한 폐색체
CA2416383A1 (en) Solution-, dispersion- or emulsion-producing film dermatics
KR890701164A (ko) 피부침투성 치료 시스템
DE69121881T2 (de) Hautelektrodenaufbau und dazugehöriges gerät zur transdermalen verabreichung von heilmitteln
IE54286B1 (en) Drug delivery device
KR900701274A (ko) 남용 가능성을 감소시킨 용량 제형
US5227169A (en) Sorbitan esters as skin permeation enhancers
ATE14527T1 (de) Auftragsvorrichtung fuer pharmazeutische wirkstoffe, ihre herstellung und gebrauch.
DK0724885T3 (da) Pernasal sammensætning og pernasalt præparat indeholdende dette
AU4923500A (en) Device and method for increasing the transdermal permeation of medicaments
BR0100151A (pt) Artigo absorvente
KR950702811A (ko) 프린트 경피약제투여장치(Printed Transdermal Drug Delivery Device)
CA2229185A1 (en) Plaster structure for iontophoresis
US5863941A (en) Method and composition of a topical treatment of inner ear and labyrinth symptoms
KR850700218A (ko) 약학 조성물
KR900013993A (ko) 활성물질의 국소 또는 계통적 투여를 위한 단계적 약물 방출을 나타내는 경피 시스템 및 그 용도
JPS6485912A (en) User-activating transdermal treatment system
ES2058627T3 (es) Sistema terapeutico para la administracion retardada y dirigida a traves de la piel o de las mucosas de sustancias activas.
DE59603246D1 (de) Flächenstabilisierte pharmazeutische zubereitung zur anwendung auf der haut
Sahu et al. Medicated transdermal therapeutic systems: An updated overview
JPS577412A (en) Plaster

Legal Events

Date Code Title Description
A201 Request for examination
SUBM Surrender of laid-open application requested